Partial
Mostly Aligned
Patient Risk:
Low
Summary
Overall partial alignment with FDA label; several claims align with description and reconstitution steps, but critical dosing, stability, and safety statements are contradicted or omitted. Some administration details are not supported by the labeled sections.
Category Scores
Accurate Statements
Novarel is chorionic gonadotropin, injectable.
DESCRIPTION
Novarel comes as a lyophilized powder in 10,000 USP units per vial.
DESCRIPTION, HOW SUPPLIED
Novarel requires reconstitution with a diluent like Bacteriostatic Water for Injection (0.9% benzyl alcohol preserved) before subcutaneous or intramuscular use.
DESCRIPTION
Remove the plastic flip-off cap from the Novarel vial and wipe the vial stopper with a disinfectant swab.
DOSAGE AND ADMINISTRATION
The resulting solution contains 1,000 USP units per mL.
DOSAGE AND ADMINISTRATION
Inspect for clarity post-mixing.
DOSAGE AND ADMINISTRATION
Using incorrect diluent volume alters concentration.
DOSAGE AND ADMINISTRATION
Reconstituted: Refrigerate at 2-8°C; discard after 60 days or if discolored/particulate.
DESCRIPTION (partially supported)
Unsupported Statements
Draw 10 mL of diluent into a sterile syringe.
Absent in cited label sections; exact diluent volume not specified in provided sections.
Slowly inject the diluent into the vial, directing the stream against the vial wall to avoid foaming.
Foaming/directed-injection instructions not explicitly described in the cited label sections.
Gently swirl the vial until the powder fully dissolves—do not shake.
Swirl vs shake guidance not explicitly described in the cited label sections.
Draw the exact dose into a syringe, ensuring no air bubbles.
Exact dosing technique with air-bubble avoidance not explicitly described in the cited label sections.
Unreconstituted: Store at room temperature (15-30°C), protected from light.
Unreconstituted storage conditions not provided in the cited sections.
Storing at room temperature post-mixing risks potency loss.
Post-mixing room-temperature stability not specified in the cited sections.
Bacteriostatic Water prevents bacterial growth for multi-dose use; sterile water is for single-dose only, as it lacks preservative.
Diluent preservative guidance not explicitly described in the cited sections.
Always match vial instructions.
Vague, not a label-specific instruction; not directly supported by the cited sections.
Rotate injection sites (abdomen, thigh).
Site-rotation guidance not explicitly described in the cited sections.
Consult a healthcare provider for training, especially in fertility treatments.
Provider-training guidance not explicitly described in the cited sections.
Contradictions
Low
AI Statement
It is stable for 60 days if refrigerated (2-8°C) after mixing.
Label Reference
DESCRIPTION
Low
AI Statement
Use immediately if using sterile water without preservative.
Label Reference
DESCRIPTION
Low
AI Statement
Administer per prescription, typically 5,000-10,000 units subcutaneously or intramuscularly.
Label Reference
DOSAGE AND ADMINISTRATION
Important Omissions
Explicit contraindications and boxed warnings sections.
Importance:
High
Pregnancy safety/pediatrics considerations and specific populations guidance.
Importance:
High
Indication-specific approved dosing regimens (fertility indications) and their exact labeling guidance.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
Overall partial alignment with label; significant misstatements involve stability, dosing scope, and safety details, but no explicit high-risk statements identified beyond potential misinterpretation of dosing.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Need exact verbatim alignment with label sections for reconstitution, stability, diluent volumes, and dosing regimens.
Suggested Improvement
Cross-check all claims against the FDA-approved label sections, ensuring precise stability post-mixing (e.g., 30 days, not 60), diluent type/volume, and dosage instructions for the indicated indications; explicitly reference contraindications, boxed warnings, and population-specific guidance.